Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mark, Rubino"'
Autor:
R. Amy Puenpatom, Rami Ben-Joseph, Chunmay Fu, Kent H. Summers, Robert L. Ohsfeldt, Mark Rubino
Publikováno v:
Journal of Managed Care Pharmacy. 17:367-376
The utilization of high-potency opioids is an important component of chronic pain management, and appropriate utilization of these medicines is a common concern of payers. Two of the most commonly prescribed oral long-acting opioids, oxycodone contro
Autor:
J D Roberts, L C Hsi, J E Adair, Kenneth B. Tomer, Thomas E. Eling, Tasuku Matsuoka, Kenneth Olden, Mark Rubino, Fred B. Lih, Masakazu Yashiro, Kousei Hirakawa
Publikováno v:
British Journal of Cancer
Background: Dietary (n-6)-polyunsaturated fatty acids influence cancer development, but the mechanisms have not been well characterised in gastric carcinoma. Methods: We used two in vivo models to investigate the effects of these common dietary compo
Autor:
Ruchir R. Shah, Ajeet Singh, Michael C. Boyle, Arpit Tandon, Mark Rubino, Trevor K. Archer, Julie F. Foley
Publikováno v:
Molecular and cellular biology. 36(15)
SWI/SNF (switching/sucrose nonfermenting)-dependent chromatin remodeling establishes coordinated gene expression programs during development, yet important functional details remain to be elucidated. We show that the Brg1 (Brahma-related gene 1; Smar
Autor:
Mark Rubino, Gene A. Hiegel
Publikováno v:
Synthetic Communications. 32:2691-2694
Trichloroisocyanuric acid with triphenylphosphine in anhydrous acetonitrile will convert alcohols into alkyl halides.
Publikováno v:
The FASEB Journal. 28
BRG1, a catalytic subunit of the SWI/SNF ATPase chromatin-remodeling complex, plays a vital role in gene regulation and tumorigenesis. Germline SWI/SNF function loss results in early embryonic lethality at approximately E3.5 in the mouse. BRG1 necess
Autor:
Mark Rubino, Gene A. Hiegel
Publikováno v:
ChemInform. 33
Trichloroisocyanuric acid with triphenylphosphine in anhydrous acetonitrile will convert alcohols into alkyl halides.
Rho GTPases are critical components of cellular signal transduction pathways. Both hyperactivity and overexpression of these proteins have been observed in human cancers and have been implicated as important factors in metastasis. We previously showe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e6d39972308bc0b329eb7b6bc22440
https://europepmc.org/articles/PMC2742859/
https://europepmc.org/articles/PMC2742859/
Autor:
Saul N, Weingart, Elizabeth, Brown, Peter B, Bach, Kirby, Eng, Shirley A, Johnson, Timothy M, Kuzel, Terry S, Langbaum, R Donald, Leedy, Raymond J, Muller, Lee N, Newcomer, Susan, O'Brien, Denise, Reinke, Mark, Rubino, Leonard, Saltz, Ronald S, Walters
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 6
Oral chemotherapy is emerging as a new option for well-selected patients who can manage potentially complex oral regimens and self-monitor for potential complications. If a choice between oral and parenteral therapy is available, patients may opt for
Autor:
Peter J, Neumann, Jennifer A, Palmer, Norman, Daniels, Karen, Quigley, Marthe R, Gold, Schumarry, Chao, Mark, Rubino
Publikováno v:
The American journal of managed care. 14(4)
The Panel on Integrating Cost-Effectiveness Considerations into Health Policy Decisions, composed of medical and pharmacy directors at public and private health plans, was convened to (1) explore the views of health plan purchasers about cost-effecti
Autor:
Susan Mathew, Sebastian Schneeweiss, Joaquim Fernandes, Claire M. Spettell, Blake Christiansen, Troyen A. Brennan, Elliott M. Antman, Michele Toscano, Niteesh K. Choudhry, Robert J. Glynn, Alan M. Brookhart, William H. Shrank, Mark Rubino, Jerry Avorn
Publikováno v:
American heart journal. 156(1)
Background Medication nonadherence is a major public health problem, especially for patients with coronary artery disease. The cost of prescription drugs is a central reason for nonadherence, even for patients with drug insurance. Removing patient ou